NasdaqGS - Nasdaq Real Time Price
USD
Aardvark Therapeutics, Inc. (AARD)
1.2800
-0.0800
(-5.88%)
As of 12:10:17 PM EST. Market Open.
Trade AARD on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHI JEFFREY CHIEN CHUEN PH.D. Director |
Conversion of Exercise of derivative security | Feb 14, 2025 | -- |
| CORMORANT ASSET MANAGEMENT ,L.P Unknown |
Conversion of Exercise of derivative security | Feb 14, 2025 | -- |
| DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND IV, L.P. Beneficial Owner of more than 10% of a Class of Security |
Conversion of Exercise of derivative security | Feb 14, 2025 | -- |
| JONES BRYAN Chief Operating Officer |
Conversion of Exercise of derivative security | Oct 15, 2025 | 1,250 |
| LEE TIEN-LI Chief Executive Officer |
Purchase | Dec 11, 2025 | 3,025,640 |
| SUN NELSON B. Chief Operating Officer |
Sale | Sep 11, 2026 | 35,475 |
| VICKERS VENTURE FUND VI PTE, LTD. Beneficial Owner of more than 10% of a Class of Security |
Conversion of Exercise of derivative security | Feb 14, 2025 | -- |
